The microbiota-gut-brain axis: An emerging therapeutic target in chemotherapy-induced cognitive impairment
Courtney B. Subramaniam(The University of Adelaide), Hannah R. Wardill(South Australian Health and Medical Research Institute), Joanne M. Bowen(The University of Adelaide), Samantha Mayo(University of Toronto), Marc A. Gladman(The University of Adelaide), Maryam B. Lustberg(Yale Cancer Center)
Cited by 55
Related Papers
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: American Society of Clinical Oncology Clinical Practice Guideline
|Journal of Clinical Oncology|2014|1.2k
Prevention and Management of Chemotherapy-Induced Peripheral Neuropathy in Survivors of Adult Cancers: ASCO Guideline Update
|Journal of Clinical Oncology|2020|1.1k
Mitigating long-term and delayed adverse events associated with cancer treatment: implications for survivorship
|Nature Reviews Clinical Oncology|2023|296
Triple-negative breast cancer: promising prognostic biomarkers currently in development
|Expert Review of Anticancer Therapy|2020|236